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Hemorrhage in Dogs 
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(Director Prof. Dr. HAJIME HANDA) 
The present study was carried out to estimate the importance of fibrinolytic 
activity in rerupture of cerebral aneurysms. Artificial subarachnoid hemorrhage was 
induced in dogs by intrathecal arterial blood injection. The fibrinolytic activities of 
both the systemic blood and cerebrospinal fluid were measured from samples taken 
iust before, and 2, 4, 7, 9, 14 and 21 days after the hemorrhage. 
The methods employed to measure fibrinolytic activity were Lysin sepharose 
affinity chromatography and the TNP method for plasminogen and anti plasmin, the 
fibrin plate method for to↑al plasmin activity, and the Latex method for fibrin and 
fibrinogen degradation products (FDP). 
Results 
In the cerebrospinal fluid, total plasmin activity and FDP reached maximum 
mean values 2 days after intrathecal injection of whole blood and then gradually 
decreased to the pre-hemorrhage levels. However, in regard to the relative changes 
of the plasminogen and anti-plasmin in the cerebrospinal fluid, it is difficult to 
determine at what stage fibrinolysis was at the maximum level. 
As for the systemic blood, all the factors measured showed a gradual elevation 
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in activity, attained their maximum levels 7 or 9 days after the intrathecal injection, 
and then gradually decreased towards the pre-injection levels. 
Statistically, reruptures of cerebral aneurysms took place most frequently about 
one week after the initial hemorrhage. Taking this fact into account, the results 
in this study suggest that increased fibrinolytic activity of systemic blood, rather 
than that of cerebrospinal fluid, may play the main role in the mechanism of 
aneurysmal rerupture. 
Following this study, further experiments were carried out on dogs to determine 
the relation between angiospasm and fibrinolytic activity after Subarachnoid hemorshage 
After intrathecal injection of arterial blood, oxy Hb or met-Hb, Euglobulinlysis 
time (EL T) and fibrinogen (Fbg.) of systemic blood were measured regularly for about 
2 weeks, while angiospasm was estimated angiographically both 3 hours and 3 days 
afterwards. 
The observed sequential changes in the two components (angiospasm and fibri-
nolysis), suggest the following conclusions : 
1. With each of the three substances injected intrathecally, (arterial blood, 
oxy Hb and met Hb) angiospasm continuing for over 3 days was induced. 
2. The re elevation of the Fbg. value suggests either minor leakage or rerupture 
of the aneurysm rather than angiospasm. 
3. The changes with time in the EL T of systemic blood correspond closely to 
thore of FDP, plasminogen and anti plasmin measured by the affinity chromatography 
method and to total fibrinolytic activity measured by the fibrin plate method. 










































1. Lysin-sepharose affinity chromatography法お
よびTNP法による plasminogenおよびantiplasmin
の測定9)22)26).
















































a) Fraction I (anti-plasmin) 







b) Fraction I （弱し、吸着の蛋白， activatorなど）
；＼＇毒事
カラムにE液 0.75mlを流して回収しない




低い場合は，0.5M Na OHで PHを7.5＇ζ調整する．
B ・ TNP 1：去による plasminogenと anti-plasminの
測定
a) Anti-plasmin〔inhibitor）の測定（fractionI) 
25・8U勺iplasminogen 0. 3ml + 1200U 'ml 
Urokinase 0. lml 
I zs分加温（38°Cの恒温水槽）












1. 5ml (plasma) 










0. 5M PBS 0. 5ml 
12°~ TNBS 0. 5ml 
以上を褐色試験管lζ入れ加温する.90分後17%HC1
0.5mlを加え 340nmで吸光度測定を行う．
b) 使用した plasminogenの力価測定は fraction
I液の代りに， I液を 0.lml (plasma) 0. 2ml (CSF〕
加える以外は全く同様に a〕の操作を行う．
c〕 Plasm in及びplasminogenの測定（fractionII〕
































lU/ml, 2U/ml, 3U, ml, 5U, mlを段階稀釈して調
整し，各ャ 0.1 ml+O. 4 ml (I液）ずつ試験管にとり
plasm in及び antiplasminの測定と同様の操作を行
つ．
註※ I f夜…・・・0.005M. PBS 加 0. 85% Nacl 
(PH7. 5) 











レIC入れ， ζれに 0.5M CaCl2 30/il, 25u, mlトロンビ
ン0.4ml〔持田製薬）を添加して平板を作製した．試


























髄液： (Tab.l. Fig.l) plasminogenは， くも膜下
出血前lζ平均 0.244cu.1mlを呈し，血液注入後急激に
増加して， 4日後IC最高値の平均 0.496cu/ml lζ達す
る． 7日後迄はζれがほぼ維持されるが，以後漸減す


















Table 1 Successive changes of plasminogen and Anti-Plasmin activities in CSF, prepared by afinity 
chromatography on Lysin-sepharose, measured by TNP-Method after a single intrathecal 
blood injection. 
An七i-Plasmin Ac七1V1七y (cu/ml) 
Days 。
Sam le No. 
2 4 7 9 工4 21 
12 o. 722 2. 671 3.210 3.210 2.223 3.294 2.886 
13 2.032 2.176 1.432 2.230 2.746 1.687 工.563
14 0.557 2.470 1.990 1.324 0.588 Q.790 0.751 
20 0.918 2.290 2 .872 0.217 1.308 0.846 
21 o.186 1. 736 1.460 3.015 1.454 0.573 1.006 
24 2.764 2.002 2.458 1.176 2.800 1.122 1.091 
25 1.122 1.378 l. 703 l. 641 1.045 1.370 0.774 
26 0.508 1.206 3.348 2.263 0.369 0.648 0.020 
31 0.897 2.923 3.643 3.364 1.366 0 .568 0.628 
32 1. 202 2.385 2.612 2.9工7 1.625 1.345 1.143 
Mean 1. 092 2.124 2.473 2.347 1.419 1.271 1.101 
S.E. 0.244 0.173 0.252 0.274 0.293 0.256 0.238 
Plasminogen Activity (4×cu/ml) 
Days 。 2 4 Sample No. 7 9 14 21 
工2 0.061 0.108 0.工52 0 .112 0 .135 0 .115 0.126 
13 0.070 0 .116 Q.144 0 .124 o.085 0.061 0.081 
14 0.040 0.061 0.142 0.087 0.099 0.099 0.030 
20 0.081 0.124 0 .211 0.197 0.161 0.135 0.106 
21 0.076 0.101 0.103 0 .115 0.055 0.078 0.067 
24 0.067 0.070 0.128 0.150 0 .103 0.078 0.067 
25 0.073 0.106 0 .110 0.108 0.121 0.103 0.085 
26 0.064 0 .112 0 .115 0.150 0.103 0 ."128 0.101 
31 0.040 0.083 0.087 0.085 0.073 0.033 0.043 
32 0.040 0.030 o.046 0.067 0.027 0.033 0.024 
Mean 0.061 0.091 0.124 0 .119 0.097 0.086 0 .073 
S.E. 0.005 0.015 0.014 0.016 0.012 0.011 0.014 
出血前の値lζ近づく.(Fig. 2）髄液中の plasminogen 液，血殺ともに有意の変化を示さなかった．
の変動lζ類似してはいるが，血祭の場合上昇の傾向 2. total plasmin活性
は，や〉ゆるやかであり，上昇の持続が長期化しての 髄液： (Tab. 3. Fig. 3）出血前平均値は， 0.388
ち下降するのが特徴である． cu/mlであり，出血2日後lこ急激に上昇して161%1ζ 
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Fig. l Successive changes of plasminogen and Anti-Plasmin activity in CSF, prepared by affinity 
chromatography on Lysinごepharose,measured by TNP-method after a single intrathecal 
blood injection. 
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Fig. 2 Success，、rechanges of Plasminogen and Anti-Plasmin activities in PLASMA, prepared by 
affinity chromatography on Lysin-.iepharose, measured by TNP-method after a single 
intrathecal blood injection. 
Vertical bars represent standard errors of the means for 10 dogs. 
くも膜下出I飢後の線的系と脳血管筆縮についての笑験的研究 543 
Table 2 Successive changes of plasminogen and anti-plasmin activities in PLASMA, prepared by 
afinity chromatography on Lysin-sepharose, measured by TNP-method after a single 
intatheclal blood injection. 
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血猿：（Tab.4. Fig. 4）出血前平均値は1.012cu/ml 
であり，出血後緩徐lζ上昇し， 9日自において出血前






すなわち， 0.5 μg/ml以下であった． 出血 2日後で
は， 8例中5例が0.Sμg/ml, 1例が1.0μg/ml，残る
2例は陰性であり，有意の増加を示した． 4日後lζ




て陰性であった． (Tab. 5) 
換言すれば髄液中の FDP値は，出血直後IC著明lζ
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Table 3 Successive change of total plasmin activity in CSF by Fibrin Agar Plate-method after a 
single intrathecal blood injection. 
Total Plasmin Ac七ivity (cu/ml) 
Sample Days 
No. 。 2 4 7 9 14 21 
41 0・418 o.soo Q.526 0.408 o.4oo o.4oo 0.392 
42 0 .392 o.s26 0.510 0.400 o.418 0.392 0.392 
43 o.338 o.462 0.562 0.510 0.392 o.4os o.344 
47 o.378 o.soo 0.550 0.490 o.344 0.378 0.378 
49 0-392 0.732 0.480 0.370 0.392 o.4oo 0.408 
50 0.392 0.706 0.500 0.378 0.392 0.392 0.392 
51 o.4os 1.004 0.480 0.378 o.4os 0.392 0.378 
52 0.392 0.816 0.434 0,330 o-. 408 o.452 0.392 
Mean o.388 0.656 0.505 0.408 o.394 o.402 0.385 
S.E. 0.008 0.078 0.015 0.022 0.008 0.008 0.007 
0 -6 
工
( c u ImI ) 
0 . 4 
0 2 
．?? ????」?????
。。 5 IQ 15 20 
Days 
Fig. 3 Successive change of total plasmin activity in CSF by Fibrin Agar Plate-method after a 
s_ingle intrathecal blood injection. Vertical bars respresent standard errors of the means of 8 
aogs. 
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Table 4 Successive change of total r Jasmin activity in PLASMA by Fibrin Agar Plate-method after 
a single intrathecal blood injection. 
To七al Plasrnin Ac七ivity (cu/ml) 
Sample Days 
No. 。 2 4 7 9 工4 21 
41 1.050 0.900 1.340 1.340 1.340 1.110 1.210 
42 1.110 1.340 1.400 1.460 1. 720 1. 720 1. 860 
43 1. 340 1.460 1.580 1.520 1.520 1.400 1.340 
47 0.850 0.110 1.400 1. 720 2.340 1.340 1.220 
49 0. 710 0.890 1.110 1. 720 1.460 0.660 1.220 
50 0.908 0.952 1.244 1.436 1. 732 1.192 1.297 
51 1.003 l. 016 1.392 1.617 L501 1.141 1.411 
52 1.125 1. 239 1.460 1. 603 l. 795 1. 405 1.402 
Mean 1. 012 l. 060 1.366 1. 552 1.676 1.246 1. 370 





。。 5 10 15 20 Days 
Fig. 4 Successive change of total plasmin act1吋tyin PLASMA by Fibrin Agar Plate-method afアr
a single intrathecal blood injection. Vertical bars represent standard errors of the means tor 
8 dogs. 




:¥o. 41 CSF Pig. （ー〕 Act.( +) ？ぜo.41 Plasma Pig. （ー） Act. ( +) 
Fig. 5 Fibrin Plare Method 
Table 5 Successive change of FDP in CSF by LAT-method after a single 






















7 9 14 21 
0.5 
(μg/ml) 











Ni。． 。 2 斗 7 9 エ与 21 
九1 0.5 1.5 2.0 3.0 6.0 2.0 2.0 
与2 I.O 2.0 2.0 3.0 3.0 3.0 与.o
与3 エ.o 2.0 3.0 6.0 6.0 6.0 与.0
与5 エ.o l.5 3.0 3.0 3.0 1.0 工.o
与6 1.0 1.0 3.0 2,5 2.0 0.75 0.5 
与7 1.0 2.0 2.0 3.0 2.5 1.5 0.75 
与9 工.o 1.0 2.0 工.5 王.25 0.75 0.5 
.50 1.0 工.5 2 . 5 3.0 3.0 2.0 I.5 
Mean 0.398 1.500 2.与38 3.125 3.33与 2.032 1. 658 






。。 5 10 15 20 Days 
Fig. 6 Succissive change of FOP in PLASMA by LAT-method after a single intrathecal blood 
m1ect10n. 
Vertical bars represent standard errors of the means for 7 dogs. 
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Fig. 8 Ventricular system after artificial SAH. 
left : control 


















































































































































ユー グロプリン溶解時間 CELT〕とフィプリ ノーゲ













2) 1/15M りン酸緩衝液， Serensen36）法により
Na2HP04・2H209. 45 g, KH2P04 1. 8 g, 蒸溜水
lOOOmlを加えて溶解し， PH7.4として保存する．
3) トロンピン液， トロンピン（持田製薬 K.K.〕
を蒸留水で溶解し， 50単位／mlとする．
実施： I血凝 0.5mllζ前記冷酢酸水 9.5mlを加え





















従うと以下のどとくであった． (Fig. 9, 10) 
A. 全血注入群：注入3時間後においては， grade 
Iが3例， grade Hが1例であった． 3日後lこは，
? ? ?
? ?



















































Fig. 10 Angiospasm induced by intrathecal injection of arterial blood, oxy-Hb and met-Hb. 
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注入3時間後においては， grade Hが3例， grade






































10 15 20 
Fig. 1 Sequential change of plasma fibrinogen following intrathecal injection of arterial blood, 





+ 80 0・・H・........o arterial blood 
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Fig. 12 Rate of sequential change of plasma fibrinogen following intrathecal injection of arterial 
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Fig. 14 Rate of sequential change about plasma EL T following intrathecal injection of arterial blood, 
























値lζ達する急速な増加を示し，残る l例は6日後IC最 の聞にあり，平均値は 258分を呈し，個体差の比較的
高値lζ達する．最高値の平均は 270mg/dlであり，注 少い群である. 3 例は 2 日後lζ平均95~百の増加率を示
入前値lζ比して平均61%の増加に相当する．最高値を して， 12日目以後lとは注入前値を下回る値IC迄下降す
呈して以後は，それぞれ単純な減少傾向を示し，約2 る．残る 1例は，他の3例よりも遅れて，注入6日後
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なゥた 従って oxy-Hbを met-Hbiζ変化させるζ
とによって鍍縮を除去するという園部らの方法則は，
























































































① Lysin-sepharose affinity chromatography法
及ぴ TNPj法による plasminogen及び anti-
plasm inの定量
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